Valproate for treatment of bipolar disorder to be 'reconsidered' by MHRA

The use of valproate in the treatment of bipolar disorder in women who can have children is to be “reconsidered” by the Medicines and Healthcare products Regulatory Agency.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research